These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5526347)

  • 1. The hemostatic defect induced by treatment with asparaginase in leukemia.
    Heene DL; Löffler H
    Recent Results Cancer Res; 1970; 33():342-3. PubMed ID: 5526347
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood coagulation changes under L-asparaginase therapy.
    Deutsch E; Fischer M; Frischauf H; Honetz N; Lechner K; Pesendorfer F; Stych H; Weissmann A
    Recent Results Cancer Res; 1970; 33():331-41. PubMed ID: 4262281
    [No Abstract]   [Full Text] [Related]  

  • 3. [On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
    Stier HW; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1969 Feb; 94(6):253-60. PubMed ID: 5249235
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
    Zaunschirm A; Muntean W
    Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-asparaginase--clinical experience in leukaemia, lymphoma and carcinoma.
    Biggs JC; Chesterman CN; Holliday J
    Aust N Z J Med; 1971 Feb; 1(1):1-7. PubMed ID: 4934741
    [No Abstract]   [Full Text] [Related]  

  • 6. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation disorder due to asparaginase].
    De Rossi G; Conti G; DeLuca AM; Monarca B; Tribalto M
    Haematologica; 1971; 56(9):420-9. PubMed ID: 5004542
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical toxicities of L-asparaginase in treatment of leukemia and lymphoma.
    Zubrod CG
    Pediatrics; 1970 Apr; 45(4):555-9. PubMed ID: 5438160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coagulation and immunoprotein changes under L-asparaginase therapy].
    Lechler E; Schumacher K; Hirschmann WD
    Med Welt; 1971 Jan; 4():127-34. PubMed ID: 4100623
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.
    Ramsay NK; Coccia PF; Krivit W; Nesbit ME; Edson JR
    Cancer; 1977 Oct; 40(4):1398-401. PubMed ID: 269003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
    Jacquillat C; Weil M; Bussel A; Loisel JP; Rouesse T; Larrieu MJ; Boiron M; Dreyfus B; Bernard J
    Recent Results Cancer Res; 1970; 33():263-78. PubMed ID: 5292720
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemostatic disorders in massive poisoning with acute diarrhea].
    Frĕjaville JP; Bismuth C; Crabiĕ P; Gervais P; Pebay-Peyroula FC
    Rev Med Suisse Romande; 1971 Nov; 91(11):855-76. PubMed ID: 5142436
    [No Abstract]   [Full Text] [Related]  

  • 14. L-Asparaginase-induced coagulopathy during therapy of acute lymphocytic leukemia.
    Sills RH; Nelson DA; Stockman JA
    Med Pediatr Oncol; 1978; 4(4):311-3. PubMed ID: 281595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-asparaginase-induced coagulation abnormalities: report of a case.
    Hensley MF
    J Am Osteopath Assoc; 1983 May; 82(9):680-1. PubMed ID: 6575006
    [No Abstract]   [Full Text] [Related]  

  • 16. Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
    Gerhartz H; Begemann H
    Recent Results Cancer Res; 1970; 33():244-56. PubMed ID: 5292719
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy.
    Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Ito K; Matsuda T
    Am J Hematol; 1989 Sep; 32(1):20-3. PubMed ID: 2757000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation disorders during treatment with l-asparaginase preparations].
    Dobaczewski G
    Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation disorders in a chronic eosinophilic leukemia].
    Zöller H
    Munch Med Wochenschr; 1973 Jun; 115(22):1036-8. PubMed ID: 4740866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.